{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:57:24Z","timestamp":1774382244207,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe University","doi-asserted-by":"publisher","award":["THD-2016-10016"],"award-info":[{"award-number":["THD-2016-10016"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejmech.2018.05.032","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T12:39:08Z","timestamp":1527079148000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-\/T-type calcium channel blocking activity"],"prefix":"10.1016","volume":"155","author":[{"given":"David","family":"Schaller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-9509","authenticated-orcid":false,"given":"Miyase G\u00f6zde","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang Xiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-0048","authenticated-orcid":false,"given":"Gerhard","family":"Wolber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.05.032_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.05.032_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2018.05.032_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/jm00387a019","article-title":"New conformationally restrained analogues of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformation","volume":"30","author":"Baldwin","year":"1987","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00424-013-1376-z","article-title":"Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity","volume":"466","author":"Bladen","year":"2014","journal-title":"Pfl\u00fcgers. Archiv. Eur. J. Physiol."},{"key":"10.1016\/j.ejmech.2018.05.032_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Pfl\u00fcgers. Archiv. Eur. J. Physiol."},{"key":"10.1016\/j.ejmech.2018.05.032_bib6","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00424-015-1725-1","article-title":"Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels","volume":"467","author":"Gadotti","year":"2015","journal-title":"Pfl\u00fcgers. Archiv. Eur. J. Physiol."},{"key":"10.1016\/j.ejmech.2018.05.032_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1039\/C5MB00781J","article-title":"Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Ca v 1.2: a molecular modeling study","volume":"12","author":"Xu","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2018.05.032_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/abbi.2001.2484","article-title":"Homology model of dihydropyridine receptor: implications for L-type Ca2+ channel modulation by agonists and antagonists","volume":"393","author":"Zhorov","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2018.05.032_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1124\/mol.63.3.499","article-title":"Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel","volume":"63","author":"Lipkind","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.032_bib10","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/jm061245a","article-title":"Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations","volume":"50","author":"Cosconati","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib11","doi-asserted-by":"crossref","first-page":"19006","DOI":"10.1074\/jbc.M109.011296","article-title":"Structural model for dihydropyridine binding to L-type calcium channels","volume":"284","author":"Tikhonov","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nat. Publ. Gr"},{"key":"10.1016\/j.ejmech.2018.05.032_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad2395","article-title":"Structure of the voltage-gated calcium channel Cav1.1 complex","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.05.032_bib14","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1074\/jbc.271.10.5293","article-title":"Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels","volume":"271","author":"Peterson","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib15","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/j.1460-2075.1996.tb00592.x","article-title":"The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines","volume":"15","author":"Schuster","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2018.05.032_bib16","doi-asserted-by":"crossref","first-page":"18752","DOI":"10.1074\/jbc.272.30.18752","article-title":"Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis","volume":"272","author":"Peterson","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib17","doi-asserted-by":"crossref","first-page":"12730","DOI":"10.1074\/jbc.M010164200","article-title":"Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits","volume":"276","author":"Wappl","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/chan.5.2.15141","article-title":"Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCa v 1)","volume":"5","author":"Senatore","year":"2011","journal-title":"Channels"},{"key":"10.1016\/j.ejmech.2018.05.032_bib19","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","article-title":"Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists","volume":"275","author":"Yamaguchi","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib20","series-title":"Virtual Screen. Drug Discov","first-page":"379","article-title":"Protein-ligand docking and virtual screening with GOLD","author":"Cole","year":"2005"},{"key":"10.1016\/j.ejmech.2018.05.032_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.05.032_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/80400381","article-title":"Synthesis and aromatization of Hantzsch 1,4-dihydropyridines under microwave irradiation. An overview","volume":"8","author":"Vanden Eynde","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.05.032_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.31.473","article-title":"Structure\u2013activity relationships of receptor binding of 1,4-dihydropyridine derivatives","volume":"31","author":"Takahashi","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2018.05.032_bib24","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","author":"UniProt Consortium","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2018.05.032_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2018.05.032_bib26","series-title":"Chemical Computing Group Inc, Molecular Operating Environment (MOE)","first-page":"1010","year":"2015"},{"key":"10.1016\/j.ejmech.2018.05.032_bib27","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.05.032_bib28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X","article-title":"MMFF VI. MMFF94s option for energy minimization studies","volume":"20","author":"Halgren","year":"1999","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.05.032_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: orientations of proteins in membranes database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2018.05.032_bib30","series-title":"Schr\u00f6dinger Release 2016: Maestro 11.0","author":"Schr\u00f6dinger","year":"2016"},{"key":"10.1016\/j.ejmech.2018.05.032_bib31","series-title":"Schr\u00f6dinger Release 2016: Desmond 4.8","author":"Schr\u00f6dinger","year":"2016"},{"key":"10.1016\/j.ejmech.2018.05.032_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J.\u00a0Mol. Graph."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T02:06:30Z","timestamp":1569377190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418304458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"alternative-id":["S0223523418304458"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.032","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-\/T-type calcium channel blocking activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}